2026– date –
-
Zhejiang University: 200V artificial muscle specs for soft robots
Sina Finance China Overview A team led by Professor Shi Ye at Zhejiang University has developed a novel artificial muscle that operates with a mere 200 volts, paving the way for soft robots to operate without external power cables. This ... -
Silicon Li-ion Batteries: 30-40% energy density boost for drones
Ayaa Unknown Overview New silicon anode Li-ion batteries for military drones deliver a 30-40% increase in energy density compared to conventional graphite cells, reaching 350-450+ Wh/kg. This advancement significantly extends the enduran... -
Daraxonrasib: First RAS inhibitor FDA approval specs for 2026
American Association for Cancer Research (AACR) USA Overview The FDA granted several oncology approvals in Q3 2026, including the groundbreaking approval of Daraxonrasib (Rasonque), the first RAS inhibitor for pancreatic cancer. Addition... -
3D Bioprinting: Multi-layered tumor organoid specs for 2026
BIOENGINEER.ORG USA Overview Advances in 3D bioprinting have enabled the creation of multi-layered tumor organoid models that accurately replicate vascular structures, stromal compartments, and tumor-stroma interactions. This novel model... -
Aglatimagene: Candel Therapeutics NSCLC Phase 2a 2026 roadmap
Trefis USA Overview Candel Therapeutics announced compelling Phase 2a clinical trial results for its investigational non-small cell lung cancer (NSCLC) therapy, aglatimagene besadenovec, demonstrating a median overall survival (OS) of 24... -
3D Bioprinting: Tsinghua University vascular organoid specs
Scienmag China Overview Researchers at Tsinghua University reported in BMC Medicine that 3D bioprinted human vascular organoid sheets effectively form functional vascular networks and restore blood flow in ischemic limbs. These sheets in... -
FAYUVI: Ultragenyx AAV9 gene therapy FDA approval and specs
DeciBio USA Overview Ultragenyx's AAV9 gene therapy FAYUVI (rebisufligene etisparvovec-hopf) has gained full FDA approval for pediatric patients with Sanfilippo Syndrome Type A (MPS IIIA), marking the first gene therapy approved for this... -
Lonvo-z: Intellia Therapeutics’ FDA approval for CRISPR therapy
Vertex AI Search (Biotech News Outlet) USA Overview Intellia Therapeutics' in vivo CRISPR gene therapy, lonvoguran ziclumeran (lonvo-z), has received Biologics License Application (BLA) approval from the U.S. FDA for the treatment of her... -
Sartorius Eveo: Cell therapy costs cut 90% to under $40,000
Onyx Newsroom Germany Overview Sartorius announced at the Cell & Gene Meeting on the Mesa that its automated Eveo Cell Therapy Platform can reduce cell therapy manufacturing costs to under $40,000 per patient. This closed system inte... -
VIPR system: Jennifer Doudna’s discovery of CRISPR ancestor
The Times of India India Overview A research team led by Nobel laureate Jennifer Doudna at the Innovative Genomics Institute (IGI) has discovered the 'VIPR system' in viruses, which utilizes a previously unknown 'gapped' DNA coding strat...
